Stoid
09-10

$Tonix Pharmaceuticals(TNXP)$ 

Can somebody please educate me on this stocks flight path - it's got hot off the press fast track approval for it's Monkey Pox vaccine, additional funding has been raised successfully, it's got other promising big pharma projects in Phase 3 trials, highly reputable shareholders with stakes in it and it was trading at ~19 cents pre- market after getting a flurry up to ~ 24 cents and now all it wants to do in pre-market trading is go down???

Sorry, but I just can't see what I'm missing on this shitta - can you? 😳😭😷

Winning Trades
Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • aaffsmcjje
    09-11
    aaffsmcjje

    The stock offering keeps coming. Just gonna get diluted further unless something concrete appears

    • Stoid:Β 
      Cheers on the feedback boss - I did see the dilution in stockholders interests without selling shares, but they have got a couple of things in the pipeline particularly the monkey pox number and finally had some income last quarter - dunno - seems really cheap and in my price range anyway πŸ˜·πŸ˜‚
  • Semangkaka
    09-10
    Semangkaka
    Wait a sec! Where you get the info about fast track mpox vaccine and highly reputable shareholders. Its major shareholders from 1 year ago have become minor shareholders
  • Semangkaka
    09-10
    Semangkaka
    Bro, you re spot on about this shit! Number 1 is the sky high executives salary. With the employment of Thomas Englese, the total salary is at least double of TNX market cap. In other words, executives don’t care about the success of any promising projects because as long as company floats, their pockets are safe. Number 2 is too much talking with less actions and I must say this is very successful because people are buying. Number 3 is close this window and come back next year january when FDA approves their Tomnya
  • Stoid
    09-11
    Stoid
    Ere ya go doubting Thomas πŸ˜‚πŸ˜‚πŸ˜‚


    Go to profile on the company page and hit up the top of the shareholder window and it lists the main shareholders baaaa
  • Semangkaka
    09-10
    Semangkaka
    One last thing, if executives care, they can easily buy up the shares
  • Stoid
    09-11
    Stoid
    I’ll just warm up the fat boss - won’t be far away 😎
Leave a comment
9
156